Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

FOXE1 Polymorphism Interacts with Dietary Iodine Intake in Differentiated Thyroid Cancer Risk in the Cuban Population.

Ren Y, Lence-Anta JJ, Pereda CM, Chappe M, Velasco M, Infante I, Bustillo M, Turcios S, Leufroy A, Guérin T, Noël L, Lesueur F, Maillard S, Cléro E, Xhaard C, Allodji RS, Rubino C, Rodriguez R, Ortiz RM, de Vathaire F.

Thyroid. 2016 Dec;26(12):1752-1760.

PMID:
27610545
2.

Recreational Physical Activity and Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control Studies.

Xhaard C, Lence-Anta JJ, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, Danzon A, Velten M, Clero E, Maillard S, Marrer E, Bailly L, Mariné Barjoan E, Schlumberger M, Orgiazzi J, Adjadj E, Pereda CM, Turcios S, Velasco M, Chappe M, Infante I, Bustillo M, García A, Salazar S, Rodriguez R, Benadjaoud MA, Ortiz RM, Rubino C, de Vathaire F.

Eur Thyroid J. 2016 Jul;5(2):132-8. doi: 10.1159/000445887.

3.

Is there really a relationship between serum vitamin D (25OHD) levels and the musculoskeletal pain associated with statin intake? A systematic review.

Pereda CA, Nishishinya MB.

Reumatol Clin. 2016 Nov - Dec;12(6):331-335. doi: 10.1016/j.reuma.2016.03.009. English, Spanish.

4.

More than a mnemonic.

Pereda C, Weppner WG, Balinger A, Goldberger ZD, Baudendistel TE.

J Hosp Med. 2015 Aug;10(8):547-50. doi: 10.1002/jhm.2387. No abstract available.

PMID:
26018494
5.

Thyroid volume and its relation to anthropometric measures in a healthy cuban population.

Turcios S, Lence-Anta JJ, Santana JL, Pereda CM, Velasco M, Chappe M, Infante I, Bustillo M, García A, Clero E, Maillard S, Rodriguez R, Xhaard C, Ren Y, Rubino C, Ortiz RM, de Vathaire F.

Eur Thyroid J. 2015 Mar;4(1):55-61. doi: 10.1159/000371346.

6.

Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population.

Pereda CM, Lesueur F, Pertesi M, Robinot N, Lence-Anta JJ, Turcios S, Velasco M, Chappe M, Infante I, Bustillo M, García A, Clero E, Xhaard C, Ren Y, Maillard S, Damiola F, Rubino C, Salazar S, Rodriguez R, Ortiz RM, de Vathaire F.

BMC Genet. 2015 Mar 1;16:22. doi: 10.1186/s12863-015-0180-5.

7.

Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review.

García de la Peña Lefebvre P, Nishishinya MB, Pereda CA, Loza E, Sifuentes Giraldo WA, Román Ivorra JA, Carreira P, Rúa-Figueroa I, Pego-Reigosa JM, Muñoz-Fernández S.

Rheumatol Int. 2015 Sep;35(9):1447-59. doi: 10.1007/s00296-015-3241-1. Review.

PMID:
25824427
8.

Environmental, lifestyle, and anthropometric risk factors for differentiated thyroid cancer in cuba: a case-control study.

Lence-Anta JJ, Xhaard C, Ortiz RM, Kassim H, Pereda CM, Turcios S, Velasco M, Chappe M, Infante I, Bustillo M, García A, Clero E, Maillard S, Salazar S, Rodriguez R, de Vathaire F.

Eur Thyroid J. 2014 Sep;3(3):189-96. doi: 10.1159/000362928.

9.

Identification of lymphoma predictors in patients with primary Sjögren's syndrome: a systematic literature review and meta-analysis.

Nishishinya MB, Pereda CA, Muñoz-Fernández S, Pego-Reigosa JM, Rúa-Figueroa I, Andreu JL, Fernández-Castro M, Rosas J, Loza Santamaría E.

Rheumatol Int. 2015 Jan;35(1):17-26. doi: 10.1007/s00296-014-3051-x. Review.

PMID:
24899571
10.

Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells.

González FE, Ortiz C, Reyes M, Dutzan N, Patel V, Pereda C, Gleisner MA, López MN, Gutkind JS, Salazar-Onfray F.

Immunology. 2014 Jul;142(3):396-405. doi: 10.1111/imm.12264.

11.

TAPCells, the Chilean dendritic cell vaccine against melanoma and prostate cancer.

Salazar-Onfray F, Pereda C, Reyes D, López MN.

Biol Res. 2013;46(4):431-40. doi: 10.4067/S0716-97602013000400014. Review.

12.

Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients.

Reyes D, Salazar L, Espinoza E, Pereda C, Castellón E, Valdevenito R, Huidobro C, Inés Becker M, Lladser A, López MN, Salazar-Onfray F.

Br J Cancer. 2013 Sep 17;109(6):1488-97. doi: 10.1038/bjc.2013.494.

13.

Latin American Dialysis and Transplant Registry: 2008 prevalence and incidence of end-stage renal disease and correlation with socioeconomic indexes.

Cusumano AM, Garcia-Garcia G, Gonzalez-Bedat MC, Marinovich S, Lugon J, Poblete-Badal H, Elgueta S, Gomez R, Hernandez-Fonseca F, Almaguer M, Rodriguez-Manzano S, Freire N, Luna-Guerra J, Rodriguez G, Bochicchio T, Cuero C, Cuevas D, Pereda C, Carlini R.

Kidney Int Suppl (2011). 2013 May;3(2):153-156.

14.

The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses.

Durán-Aniotz C, Segal G, Salazar L, Pereda C, Falcón C, Tempio F, Aguilera R, González R, Pérez C, Tittarelli A, Catalán D, Nervi B, Larrondo M, Salazar-Onfray F, López MN.

Cancer Immunol Immunother. 2013 Apr;62(4):761-72. doi: 10.1007/s00262-012-1377-3.

PMID:
23242374
15.

Clinical presentation of acral lentiginous melanoma: a descriptive study.

Pereda C, Traves V, Requena C, Serra-Guillén C, Llombart B, Sanmartín O, Guillén C, Nagore E.

Actas Dermosifiliogr. 2013 Apr;104(3):220-6. doi: 10.1016/j.ad.2012.06.006. English, Spanish.

PMID:
22959666
16.

Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients.

Tittarelli A, González FE, Pereda C, Mora G, Muñoz L, Saffie C, García T, Díaz D, Falcón C, Hermoso M, López MN, Salazar-Onfray F.

Cancer Immunol Immunother. 2012 Nov;61(11):2067-77. doi: 10.1007/s00262-012-1268-7.

PMID:
22552381
17.

Efficacy and safety of DMARDs in psoriatic arthritis: a systematic review.

Pereda CA, Nishishinya MB, Martínez López JA, Carmona L; Evidence-Based Working Group of the Spanish Society of Rheumatology..

Clin Exp Rheumatol. 2012 Mar-Apr;30(2):282-9. Review.

PMID:
22339882
18.

Functional gap junctions accumulate at the immunological synapse and contribute to T cell activation.

Mendoza-Naranjo A, Bouma G, Pereda C, Ramírez M, Webb KF, Tittarelli A, López MN, Kalergis AM, Thrasher AJ, Becker DL, Salazar-Onfray F.

J Immunol. 2011 Sep 15;187(6):3121-32. doi: 10.4049/jimmunol.1100378.

19.

Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells.

Aguilera R, Saffie C, Tittarelli A, González FE, Ramírez M, Reyes D, Pereda C, Hevia D, García T, Salazar L, Ferreira A, Hermoso M, Mendoza-Naranjo A, Ferrada C, Garrido P, López MN, Salazar-Onfray F.

Clin Cancer Res. 2011 Apr 15;17(8):2474-83. doi: 10.1158/1078-0432.CCR-10-2384.

20.
Items per page

Supplemental Content

Loading ...
Support Center